Phase IIb trial of Multimeric-001 vaccine (M-001) in patients with Influenza
Phase of Trial: Phase II
Latest Information Update: 10 Aug 2016
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Therapeutic Use
- 10 Aug 2016 Status changed from planning to recruiting, as reported in a BiondVax Pharmaceuticals media release.
- 27 Apr 2016 According to BiondVax media release, company expected to initiate this trial in 2016.
- 19 Jun 2015 New trial record